Book Appointment
Subscribe to out newsletter today to receive latest news administrate cost effective for tactical data.
Tan DSW, Felip E, de Castro G, Solomon BJ, Greystoke A, Cho BC, Cobo M, Kim TM, Ganguly S, Carcereny E, Paz-Ares L, Bennouna J, Garassino MC, Schenker M, Kim SW, Brase JC, Bury-Maynard D, Passos VQ, Deudon S, Dharan B, Song Y, Caparica R,Johnson BE. Canakinumab Versus Placebo in Combination With First Line Pembrolizumab Plus Chemotherapy for Advanced Non-Small-Cell Lung Cancer: Results From the CANOPY-1 Trial. J Clin Oncol. 2023 Dec 1:JCO2300980. doi:
10.1200/JCO.23.00980.
Tan D , Felip E, Castro, G, SolomonB, Greystoke A, Cho B, Cobo M, Kim T, Ganguly S, et al. Abstract CT037: Canakinumab in combination with first-line (1L) pembrolizumab plus chemotherapy for advanced non-small cell lung cancer (aNSCLC): Results from the CANOPY-1 phase 3 trial. Cancer Research. 82. CT037-CT037.
10.1158/1538-7445.AM2022-CT037.
Passaro A, Wang J, Wang Y, Lee SH, Melosky B, Shih JY, Wang J, Azuma K, Juan-Vidal O, Cobo M, Felip E, Girard N, Cortot AB, Califano R, Cappuzzo F, Owen S, Popat S, Tan JL, Salinas J, Tomasini P, Gentzler RD, William WN Jr, Reckamp KL, Takahashi T, Ganguly S, Kowalski DM, Bearz A, MacKean M, Barala P, Bourla AB, Girvin A, Greger J, Millington D, Withelder M, Xie J, Sun T, Shah S, Diorio B, Knoblauch RE, Bauml JM, Campelo RG, Cho BC; MARIPOSA-2 Investigators. Amivantamab plus chemotherapy with and without lazertinib in EGFR mutant advanced NSCLC after disease progression on osimertinib: primary results from the phase III MARIPOSA-2 study. Ann Oncol. 2023 Oct 23:S0923-7534(23)04281-3. doi:
10.1016/j.annonc.2023.10.117.
Ghosh, Joydeep & Ganguly, Sandip. (2023). Pathological complete response in breast cancer: Is it truly a surrogate for outcome?. Cancer Research, Statistics, and Treatment. 6. 232-234.
10.4103/crst.crst_201_23.
Sen Dutt, Tiyas & Biswas, Bivas & Dabkara, Deepak & Ganguly, Sandip & Moses, & Midha, Divya & Geetasheree, & Dey, Debdeep & Chatterjee, Argha & Mukhopadhay, Sumit & Ghosh, Priya & Basak, Sagar & Chatterjee, Soumen. (2023). Mediastinal Sampling with Endobronchial Ultrasound in Cancer Patients: Is It Always Metastatic?. The Indian Journal of Chest Diseases and Allied Sciences. 62. 193-196.
10.5005/ijcdas-62-4-193.
Mukherjee, Arnab & Samanta, Bidisha & Sharma, Varuna & Shrestha, Aagon & Chattopadhyay, Shreshta & Bhowmick, Chitralekha & Ghosh, Joydeep & Ganguly, Sandip & Kumar Agrawal, Sanjit & Datta, Soumitra. (2023). When Do Patients with Breast Cancer Seek Help from Psycho-oncology Services? A 3-Year Retrospective Study from India. Indian Journal of Medical and Paediatric Oncology.
10.1055/s-0043-1768048.
Ghosh, Joydeep & Das, S. & Ganguly, Sandip & Banerjee, S. & Chawla, Tanuj & Roy, S. & Biswas, Bivas & Mallath, Mohandas & Roy, M.. (2023). P-48 Outcomes of early gall bladder cancer (GBCA): A retrospective analysis from a tertiary care centre in India. Annals of Oncology. 34. S30.
10.1016/j.annonc.2023.04.104.
Chan, Stephen & Ryu, Min-Hee & Waked, Imam & Shao, Yu-Yun & Tai, Wai & Breder, Valeriy & Alolayan, Ashwaq & Ganguly, Sandip. (2023). Real-world registry of patients with unresectable hepatocellular carcinoma: The OREIOS study.. Journal of Clinical Oncology. 41. TPS618-TPS618.
10.1200/JCO.2023.41.4_suppl.TPS618.
Dutta A, Mungle T, Chowdhury N, Banerjee P, Gehani A, Sen S, Mallath M, Roy P, Krishnan S, Ganguly S, Banerjee S, Roy M, Saha V. Characteristics and outcomes of gallbladder cancer patients at the Tata Medical Center, Kolkata 2017-2019. Cancer Med. 2023 Feb 13.
doi: 10.1002/cam4.5677. Epub ahead of print. PMID: 36779618.
Roy S, Ghosh J, Ganguly S, Biswas B, Bhaumik J. First-line Rucaparib Plus Bevacizumab Maintenance Completed One-Year in Germline BRCA1-Mutated Advanced Ovarian Cancer. Cureus. 2022 Dec 13;14(12):e32493.
doi: 10.7759/cureus.32493. PMID: 36644062; PMCID: PMC9837332.
Dutt TS, Biswas B, Dabkara D, Ganguli S, Moses, Midha D, Geetasheree, Dey D, Chatterjee A, Mukhopadhay S, Ghosh P, Basak S, Chatterjee S. Mediastinal Sampling with Endobronchial Ultrasound in Cancer Patients: Is It Always Metastatic?. Indian J Chest Dis Allied Sci 2020; 62 (4):193-196.
Chawla, Tanuj & Ghosh, Joydeep & Ganguly, Sandip & Biswas, Bivas & Arora, N. & Vinarkar, Sushant & Patra, A. & Jha, A. & Mishra, D. & Mallath, M.K.. (2022). 272P Correlation of dihydropyrimidine dehydrogenase gene mutation with toxicity among gastrointestinal cancers (GI) taking 5-fluorouracil-based chemotherapy: Experience from a tertiary cancer center in eastern part of India. Annals of Oncology. 33. S1539.
10.1016/j.annonc.2022.10.299.
Mondal D, GangulyS, Ghosh J, Pandey P, Roy S & Biswas B. 18P Trastuzumab in HER2-amplified or overexpressed gallbladder cancer: Experience from an Indian cancer center. Annals of Oncology. 33. S1389.
10.1016/j.annonc.2022.09.019.
Ganguly S, Mukherjee N, MandalS, Roy S, Agarwal SK, Biswas B, Ghosh J. Efficacy of cyclin-dependent kinase 4/6 inhibitors in patients with metastatic hormone positive breast cancer: a single institutional study from India. ecancermedicalscience. 16.
10.3332/ecancer.2022.1450.
Mondal D, GangulyS, Roy S, Ghosh J, Pandey P & Biswas B. EP16.02-006 Evaluation of Carcinoembryonic Antigen (CEA) as Predictive Marker in Patients with Metastatic Non-small Cell Lung Cancer. Journal of Thoracic Oncology. 17. S573.
10.1016/j.jtho.2022.07.1037.
Mondal D, GangulyS, Roy S, Ghosh J, & Biswas B. EP08.02-040 Dacomitinib Induced Febrile Neutropenia: a Rare Serious Adverse Event. Journal of Thoracic Oncology. 17. S415-S416.
10.1016/j.jtho.2022.07.722
Mondal D, GangulyS, Roy S, Ghosh J, Chatterji S, & Biswas B. EP06.01-005 COVID-19 and Post-COVID Outcomes in Lung Cancer Patients: Experience from an Indian Cancer Center. Journal of Thoracic Oncology. 17. S303-S304.
10.1016/j.jtho.2022.07.520.
Mondal D, Palo U, Ghosh J, Ganguly S, Roy S. , Biswas B et al. 611P Clinical characteristics and outcomes in ultra high-risk gestational trophoblastic neoplasia: Experience from an Indian cancer center. Annals of Oncology. 33. S824-S825.
10.1016/j.annonc.2022.07.739.
Mondal D, Palo U, Ghosh J, Ganguly S, Roy S. , Biswas B et al. 611P Clinical characteristics and outcomes in ultra high-risk gestational trophoblastic neoplasia: Experience from an Indian cancer center. Annals of Oncology. 33. S824-S825.
10.1016/j.annonc.2022.07.739.
Chakraborty S, Chatterjee S. , Backianathan S, Lal P, Gupta S, Ahmed R, Misra S Solomon P, Balakrishnan R, Bhusal S, Guha D, Das M, Joseph K, Mahata A, Mandal S, Kumari A, Godson H, Ganguly S, et al HYPORT Adjuvant Acute toxicity and patient dosimetry quality assurance results Interim Analysis. Radiotherapy and Oncology. 174.
10.1016/j.radonc.2022.07.003.
Mondal D, Ganguly S, Ghosh J, Roy S, Pandey P, Dabkara D, Nair R & Biswas, B. . High-sensitivity C-reactive protein as prognostic and predictive marker in metastatic non-small cell lung carcinoma : A prospective single center study.. Journal of Clinical Oncology. 40. e21101-e21101.
10.1200/JCO.2022.40.16_suppl.e21101.
Pandey P, Dabkara D, Ganguly S, Ghosh J, Roy S, Mondal D, Gupta S, Nair R Biswas B. . Early metabolic syndrome in testicular germ cell tumors : A prospective study from India.. Journal of Clinical Oncology. 40. e17010-e17010.
10.1200/JCO.2022.40.16_suppl.e17010.
Mondal D Ganguly S, Ghosh J, Pandey P. Roy S, Pipara A, Roy, M. & Biswas, B. . P-294 Colon carcinoma in adolescents and young adults, not so rare: Experience from an Indian cancer center. Annals of Oncology. 33. S351.
10.1016/j.annonc.2022.04.383.
Roy S ,Ghosh J & Ganguly S.. How I Treat Advanced Head Neck Cancer. Indian Journal of Medical and Paediatric Oncology. 10.1055/s-0042-1742320. ● Biswas B, Roy S, Ganguly S. Malignant melanoma in India – Is it time to set the wheels in motion?. Cancer Research, Statistics, and Treatment. 5.
10.4103/crst.crst_37_22.
Roy S, Ganguly S & Biswas B. . Does REVEL reveal an attractive option after platinum failure in advanced non-small-cell lung cancer in the Indian population?. Cancer Research, Statistics, and Treatment. 5. 347.
10.4103/crst.crst_38_22.
Biswas B, Biswas G Ganguly S, Ghosh J, Roy Sh, Kumar Roy M, Pipara A, Karmakar J, Mukherjee N, Chakraborty S, Kumar Mishra D, Midha D, Dabkara D . Not so ‘rare’ – an example of malignant melanoma in India: report from a tertiary cancer centre ecancer 15 1335.
Ganguly S, Ghosh J, Mishra D, Biswas G et al. Early Experience with Dabrafenib–Trametinib Combination in Patients with BRAF-Mutated Malignant Melanoma—A Single-Center Experience. SAJC (ahead of print)
Ghosh J, Dey S, Modal D, Ganguly S et al. Clinicopathological features and outcomes of choriocarcinoma: A retrospective analysis from an Indian tertiary cancer center. Cancer ResearchStatistics and Treatment 4(3):486-91
Dabkara D, Ganguly S, Ghosh J, Mukherjee S, Gupta S et al. Clinicopathological characteristics,prognostic factors and treatment outcomes of seminomatous germ cell tumours from a tertiary cancer centre in eastern India. The National medical journal of India 34(2):68-72
Ganguly S, Gargy S, Basu A, Chatterjee M, Ghosh A et al. Multidisciplinary management of ovarian germ cell tumours-a single institutional study from India.ecancermedicalscience 15:1290
Roy S, Ghosh J, Ganguly S, Mondal D, Dabkara D, Chatterjee S, Biswas B. Outcome of COVID- 19 in Solid Organ Malignancies: Experience From a Tertiary Cancer Center in Eastern India. JCO Global Oncology7(7):1374-1379
Ghosh J, Chatterjee M, Ganguly S, Datta A, Biswas B, Mukherjee G et al. PDL1 expression and its correlation with outcomes in non-metastatic triple-negative breast cancer (TNBC). ecancer 2021, 15:1217
Biswas B, Ganguly S, Ghosh J, Roy S, Bakshi R, Dabkara D. Real-world experience of dacomitinib in EGFR mutated advanced NSCLC: A single center experience from India. J Clin Oncol 39, 2021 (suppl 15; abstr e21043)
Ghosh J, Arun I, Ganguly A, Ganguly S. Cutaneous metastases in a patient with adenocarcinoma of the stomach. Indian J Dermatol Venereol Leprol, doi:10.25259/IJDVL_657_20.
Ganguly S, Ghosh J, Gehani A, Basu A, Chatterjee M, Dabkara D, Biswas B. Non small cell lung cancer metastasis to unusual sites: A retrospective case series. Cancer Res Stat Treat 2021;4;50-4
Biswas B, Dabkara, D, Sengupta, M, Ganguly S et al. Multimodality treatment outcome in patients with primary malignant mediastinal germ cell tumor in adults. Cancer Reports. 020;e1306.
https://doi.org/10.1002/cnr2.1306
Ganguly S, Alphones S, Ghosh P, Midha D, Ghosh J, Biswas B. Rectal cancer with breast metastasis: A case report with review of literature. Cancer Res StatTreat 2020 ;3:627-9.
Basu A, Chatterjee M, Ghosh J, Ganguly S, Biswas B, Dabkara D. Leptomeningeal metastasis in lung cancer: Not always a gloomy picture. Cancer Res Stat Treat 2020 Sep;3:619-21.
Biswas B, Ganguly S, Ghosh J. Olaparib in metastatic castration resistant prostate cancer. NEJM. 2021.284(12) 1174-1175.
Chatterjee, S., Chakraborty, S. & HYPORT Adjuvant Author Group. Hypofractionated radiation therapy comparing a standard radiotherapy schedule (over 3 weeks) with a novel 1-week schedule in adjuvant breast cancer: an open-label randomized controlled study
(HYPORT-Adjuvant)—study protocol for a multicentre, randomized phase III trial.Trials 21, 819 (2020). https://doi.org/10.1186/s13063-020-04751-y
Patel A, Gupta VG, Biswas B, Das CK, Batra A, Ganguly S, Bhetanabotla S. Revisiting FulvestrantDosing in Uncertain Economic Times. JCO Global Oncology 2021 :7, 1-3
Ganguly S, Ghosh J, Biswas B, Dabkara D.Ado-trastuzumab Emtansine – The Monoclonal Drug Conjugate in Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer. IJMPO 2020;41: 218-220.
Ghosh J, Das J, Ganguly S, Biswas B, Dabkara D. Cardiac metastasis from squamous cell carcinoma of the buccal mucosa: A case report and review of the literature. Cancer Res Stat Treat 2020;3:617-9
Ghosh J, Ganguly S, Mondal D, Pandey P, Dabkara D, Biswas B. “Perspective of Oncology Patients During COVID-19 Pandemic: A Prospective Observational Study From India.” JCO Global Oncology, no.6 (2020): 844–51. https://doi.org/10.1200/GO.20.00172.
Ghosh S, Ganguly S, Ghosh J, Biswas B, Dabkara D. A novel oxaliplatin desensitization protocol:Short, safe, and effective. Indian J Med Paediatr Oncol 2020;41:287-8
Dabkara D, Ganguly S, Ghosh J et al. How We Treat Genitourinary Cancers During COVID-19 Pandemic?Asian Pacific Journal of Cancer 2020;5(s1); 147-152
Pushpam D, Garg V, Ganguly S, Biswas B. Management of Refractory Pediatric Sarcoma: Current Challenges and Future Prospects. Onco Targets Ther. 2020;13:5093-5112.https://doi.org/10.2147/OTT.S193363
Ghosh J, Ganguly S, Biswas B, Dabkara D, Srivastava P, Patel A, Batra A, Mehta P. Systemic treatment of gastroesophageal cancer during SARS-CoV2. Indian J Med Paediatr Oncol 2020;41:141-3
Biswas B, Ganguly S, Dabkara D, Ghosh J, Srivastava P, Mehta P, Patel A, Bhethanabhotla S, Batra A, Pramanik R, Gupta VG, Das CK, Mahindru S. How we treat lung cancer during SARS- Cov-2 (COVID-19)pandemic in India?. Indian J Med Paediatr Oncol 2020;41:149-52
Patel A, Batra U, Prasad KT, Dabkara D, Ghosh J, Sharma M, Singh N, Suresh P, Jain P, Malik PS, Choudhary P, Ganguly S, Khurana S, Ms S, Bothra S, Muthu V, Biswas B. Real world experience of treatment and outcome in ALK-rearranged metastatic non small cell lung cancer: A multicenter study from India. Curr Probl Cancer. 2020 Jun;44(3):100571. doi: 10.1016/j.currproblcancer.2020.100571. Epub 2020Mar 17. PMID: 32234264.
Gupta P, Saha K, Vinarkar S, Banerjee S, Choudhury SS, Parihar M, Midha D, Mukherjee G, Lingegowda D, Chatterjee S, ArunsinghS M, Shrimali R, Ganguly S, Dabkara D, Biswas B, Mishra DK, Arora N. Next generation sequencing in lung cancer: An initial experience from India. Curr Probl Cancer. 2020 Jun;44(3):100562. doi: 10.1016/j.currproblcancer.2020.100562. Epub 2020 Feb 28. PMID: 32178863.
Prasad KT, Muthu V, Biswas B, Malik PS, Dabkara D, Ganguly S, Ghosh J, Kataria B, Khurana S, Verma S, Singh N. Utility and safety of maintenance chemotherapy in advanced non-small cell lung cancer across various performance status categories: real-world experience. Curr Probl Cancer. 2020 Jun;44(3):100565. doi: 10.1016/j.currproblcancer.2020.100565. Epub 2020 Mar 5. PMID: 32173058
Kumar S, Joga S, Biswas B, Dabkara D, Kuruswamy TP, Singh N, Malik PS, Khurana S, Ganguly S, Muthu V, Batra U. Immune checkpoint inhibitors in advanced non–small cell lung cancer: A metacentric experience from India. Current Problem in Cancer. Jan 2020 (0nline)
Ghosh J, Ghosh A, Bhaumik J, Zameer L, Roy P, Chakraborty B, Roy A, Rai S, Mathai S, Ganguly S, Dabkara D, Ghosh P. A rare case of hepatoid carcinoma of ovary with mini review of literature. IndianJournal of Gynaecologic Oncology. 18,27 (2020)
Ganguly S, Biswas B, Bhattacharya S. Clinicopathological characteristics and treatment outcome in small cell lung cancer: A single institutional experience from India. Lung India. 2020;37(2):134-139
Ghosh J, Ganguly S, Dabkara D, Biswas B, Chatterjee A, Mukhopadyay S, Chandra A, Sen S, Dey D. Metachronous muscle metastasis in a case of metastatic gallbladder cancer with TP35 gene mutation: A rare case report. SAJC. 2019;8(4)240
Ghosh J, Ghosh A, Midha D, Banerjee P, Chakraborty B, Roy A, Rai S, Mathai S, Ganguly S, Dabkara D, Biswas B, Bhaumik J. Clinical and Pathological Characteristics and Outcomes of Clear Cell Carcinoma of Ovary: A Tertiary Cancer Centre Data. Indian journal of Gynaecologic Oncology. 17,80 (2019)
Ganguly S, Biswas B, Ghosh J,Dabkara D. Metastatic stomach cancer: Real world scenario from a developing country. SAJC. 2018;7(3) 171-174. ● Chawla T, Thambudorai R, Ashok A, Roy B, Ghosh J, Ganguly S, Roy P, Mallath M: 783P Perioperative chemotherapy with docetaxel, oxaliplatin, fluorouracil and leucovorin (FLOT) versus epirubicin, platinum and capecitabine or flourouracil (EOX/ECF) in resectable gastric or gastroesophageal junction adenocarcinoma: Safety and response data from India. Annals of Oncology 10/2019;
30(Supplement_5).,DOI:10.1093/annonc/mdz247.109
Biswas B, Dabkara D, Ganguly S, Ghosh J: 544P Lung cancer in adolescent & young adults: Single center experience from Eastern India. Annals of Oncology 11/2018; 29(suppl_9).,DOI:10.1093/annonc/mdy425.054
Ganguly S, Biswas B, Ghosh J, P1.12-19 Clinico-Pathological Characteristics and Treatment Outcome in Small Cell Lung Cancer: A Single Institutional Experience. Journal of Thoracic Oncology
10/2018;13(10):S580-S581., DOI:10.1016/j.jtho.2018.08.854
Biswas B, Dabkara D, Ganguly S, et alOutcome and Prognostic Factors in ALK+ve MetastaticAdenocarcinoma of Lung: Single Center Experience From Eastern India. Journal of Thoracic Oncology10/2018; 13(10):S869-S870., DOI:10.1016/j.jtho.2018.08.1567
Biswas B, Ganguly S, Dabkara D, Ghosh J: P26 Lung Cancer in Adolescent & Young Adults: Single Center Experience from Eastern India. Journal of Thoracic Oncology 09/2018;
13(9):S171.,DOI:10.1016/j.jtho.2018.07.065
itutional Experience. Journal of Thoracic Oncology
10/2018;13(10):S580-S581., DOI:10.1016/j.jtho.2018.08.854
Dabkara D, Ganguly S, Biswas B, Ghosh J. Metronomic cyclophosphamide in metastatic castration resistant prostate cancer : Experience from a tertiary cancer center. IJC. 2018; 55(1):94-97.
Biswas B, Ganguly S, Ghosh J,Batra A. Cisplatin induced hearing loss in children. Natl Med J India. 2017; 30(6): 327-28
Biswas B, Dabkara D, Ganguly S, Prasad E. Consolidation chemotherapy after concurrent chemoradiotherapy in locally advanced non-squamous cell lung cancer:when, whom and how much? Natl Med J India. 2017; 30(1): 26-27
Biswas B, Dabkara , Ganguly S.In – transit metastasis from malignant melanoma. Natl Med J India.2017;30(5):297
Biswas B, Dabkara D, Ganguly S. Survival of patients with metastatic breast cancer with or without locoregional therapy. The Lancet Oncology, vol 16, No 16e586-e587,dec 2015.
Biswas B, Dabkara D, Ganguly S, Dwary AD, Ghosh I, Sen S et al. High incidence of early metabolic syndrome in germ cell tumor: Report from a tertiary cancer center in India; J Clin Oncol. Vol 34, No 2_suppl2016: 488
Ganguly S, Lakshmaiah KC, Jacob LA, Babu S, Dasappa L, Govind Babu KS. Performance of Sokal andEutos Scores for Predicting Cytogenetic and Molecular Response in Newly Diagnosed ChronicMyeloid Leukemia-Chronic Phase Patients on Imatinib. Indian J Hematol Blood Transfus. March 2016
Babu GK, Thanky A, Jacob LA, Suresh Babu M C, Dasappa L, Ganguly S. Outcome of young adults with chronic myeloid leukemia treated with upfront imatinib: A single institutional experience. J Appl Hematol 2015;6:157-61
Ganguly S, Setty GK, Mallekavu SB, Tagarapura S. Primary rib osteosarcoma: A rare entity. Clin CancerInvestig J 2015;4:375-7
Babu S, Pasha T, Guruprasad B, Ganguly S, Srivatsa K, Padma M et al. Parameningealrhabdomyosarcoma- Single institution retrospective study. Austral-Asian Journal ofCancer.2014;13(2):53-57
Suresh TM, Babu S, Ganguly S, Babu KG, Lakshmaiah KC, Shankaranand B. Burkitt lymphoma of bone: A single institutional experience. Onc Gas Hep Rep 2014;3:23-5.Published a case series